With priority review granted for Emergent's sNDA for OTC Narcan nasal spay. FDA’s deadline under PDUFA for a decision is 29 March. • Source: Shutterstock
Explore how consumer health is evolving. On the go.
David Ridley hosts in-depth conversations with industry leaders.
